These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5868481)

  • 1. Electron microscopic observations in the substantia nigra of mouse during reserpine administration.
    Bak IJ
    Experientia; 1965 Oct; 21(10):568-70. PubMed ID: 5868481
    [No Abstract]   [Full Text] [Related]  

  • 2. The ultrastructure of the substantia nigra and caudate nucleus of the mouse and the cellular localization of catecholamines.
    Bak IJ
    Exp Brain Res; 1967; 3(1):40-57. PubMed ID: 6030999
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neuronal types of rat substantia nigra and striatum and effects on them of chronic chlorpromazine administration. Quantitative light and electron microscopic morphometry].
    Yoshida H
    Fukuoka Igaku Zasshi; 1986 Feb; 77(2):144-72. PubMed ID: 3710409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electron microscopic study of the pigment granules in the substantia nigra].
    Hirosawa K
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):831-8. PubMed ID: 4980043
    [No Abstract]   [Full Text] [Related]  

  • 5. [Submicroscopic catecholamine stores as sites of attack of the psychopharmaca, reserpine and monoamine oxidase inhibitors].
    Hassler R; Bak IJ
    Nervenarzt; 1966 Nov; 37(11):493-8. PubMed ID: 5983176
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus.
    Tonon G; Saiani L; Spano PF; Trabucchi M
    Brain Res; 1979 Jan; 160(3):553-8. PubMed ID: 217486
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a cortico-nigral tract? A comment based on experimental electron microscopic observations in the cat.
    Rinvik E; Walberg F
    Brain Res; 1969 Aug; 14(3):742-4. PubMed ID: 5822443
    [No Abstract]   [Full Text] [Related]  

  • 8. Reserpine treatment increases PEC-60-like immunoreactivity in the substantia nigra of the male rat as determined by radioimmunoassay.
    Fuxe K; Ostenson CG; Aguirre JA; Efendic S; Agerberth B; Mutt V
    Acta Physiol Scand; 1991 Nov; 143(3):357-8. PubMed ID: 1772043
    [No Abstract]   [Full Text] [Related]  

  • 9. The primate substantia nigra: a Golgi and electron microscopic study.
    Schwyn RC; Fox CA
    J Hirnforsch; 1974; 15(1):95-126. PubMed ID: 4135903
    [No Abstract]   [Full Text] [Related]  

  • 10. Electron microscopic studies on pigment granules in the substantia nigra and locus coeruleus of the Japanese monkey (Macaca fuscata yakui).
    Hirosawa K
    Z Zellforsch Mikrosk Anat; 1968; 88(2):187-203. PubMed ID: 4972310
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line--an experimental cell model for dopamine toxicity studies.
    Fuentes P; Paris I; Nassif M; Caviedes P; Segura-Aguilar J
    Chem Res Toxicol; 2007 May; 20(5):776-83. PubMed ID: 17425337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence and electron microscopic studies of the early development of the substantia nigra and area ventralis tegmenti in the fetal rabbit.
    Tennyson VM; Mytilineou C; Barrett RE
    J Comp Neurol; 1973 May; 149(2):233-58. PubMed ID: 4707733
    [No Abstract]   [Full Text] [Related]  

  • 14. 2-Methyl-1,2,3,4-tetrahydroisoquinoline does dependently reduce the number of tyrosine hydroxylase-immunoreactive cells in the substantia nigra and locus ceruleus of C57BL/6J mice.
    Fukuda T
    Brain Res; 1994 Mar; 639(2):325-8. PubMed ID: 7911392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats.
    Biggs CS; Fowler LJ; Whitton PS; Starr MS
    Eur J Pharmacol; 1996 Mar; 299(1-3):83-91. PubMed ID: 8901010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurons containing monoamines in cat brain stem. I. Topographic study by histofluorescence and histochemistry].
    Pin C; Jones BE; Jouvet M
    J Physiol (Paris); 1968; 60 Suppl 2():519. PubMed ID: 5735027
    [No Abstract]   [Full Text] [Related]  

  • 19. ELECTRON MICROSCOPIC OBSERVATIONS ON THE HUMAN SUBSTANTIA NIGRA.
    D AGOSTINO AJ; LUSE SA
    Neurology; 1964 Jun; 14():529-36. PubMed ID: 14161750
    [No Abstract]   [Full Text] [Related]  

  • 20. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat.
    Bolam JP; Smith Y
    Brain Res; 1990 Oct; 529(1-2):57-78. PubMed ID: 1704287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.